01

Ruxolitinib Clears Steroid-Refractory Sweet Syndrome in PV Case

A Swiss case report shows ruxolitinib cleared steroid-refractory histiocytoid Sweet syndrome in six weeks in a PV patient already in hematologic complete remission.